193 related articles for article (PubMed ID: 11454082)
1. Overexpression of transforming growth factor-beta3 immunohistochemical staining in extramammary Paget's disease, but downregulated expression in Bowen's disease.
Kawakami T; Soma Y; Mizoguchi M; Saito R
Int J Dermatol; 2001 Apr; 40(4):262-7. PubMed ID: 11454082
[TBL] [Abstract][Full Text] [Related]
2. Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease.
Kawakami T; Soma Y; Mizoguchi M; Saito R
Dermatology; 2001; 202(1):9-15. PubMed ID: 11244221
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of p2lWaf1/Cip1 immunohistochemical staining in Bowen's disease, but not in disseminated superficial porokeratosis.
Kawakami T; Saito R; Takahashi K
Br J Dermatol; 1999 Oct; 141(4):647-51. PubMed ID: 10583111
[TBL] [Abstract][Full Text] [Related]
4. Immunolabeling pattern of syndecan-1 expression may distinguish pagetoid Bowen's disease, extramammary Paget's disease, and pagetoid malignant melanoma in situ.
Bayer-Garner IB; Reed JA
J Cutan Pathol; 2004 Feb; 31(2):169-73. PubMed ID: 14690462
[TBL] [Abstract][Full Text] [Related]
5. Pagetoid squamous cell carcinoma in situ (pagetoid Bowen's disease) of the external genitalia.
Raju RR; Goldblum JR; Hart WR
Int J Gynecol Pathol; 2003 Apr; 22(2):127-35. PubMed ID: 12649666
[TBL] [Abstract][Full Text] [Related]
6. Co-existence of extramammary Paget's disease and Bowen's disease of vulva.
Goyal T; Varshney A; Solanki R
Indian J Dermatol Venereol Leprol; 2014; 80(6):530-3. PubMed ID: 25382511
[TBL] [Abstract][Full Text] [Related]
7. In-situ squamous cell carcinoma (Bowen's disease) with divergent adnexal differentiation.
Slater DN; Parsons MA; Mudhar H
Histopathology; 2003 Jul; 43(1):100. PubMed ID: 12823722
[No Abstract] [Full Text] [Related]
8. Bowen's disease, Paget's disease, and malignant melanoma in situ.
Rosen L; Amazon K; Frank B
South Med J; 1986 Apr; 79(4):410-3. PubMed ID: 2422766
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous human papillomavirus 6 (HPV 6) -positive condyloma acuminatum, HPV 31-positive Bowen's disease, and non HPV-associated extramammary Paget's disease coexisting within an area presenting clinically as condyloma acuminatum.
Egawa K; Honda Y
Am J Dermatopathol; 2005 Oct; 27(5):439-42. PubMed ID: 16148417
[TBL] [Abstract][Full Text] [Related]
10. p63 constitutes a useful histochemical marker for differentiation of pagetoid Bowen's disease from extramammary Paget's disease.
Memezawa A; Okuyama R; Tagami H; Aiba S
Acta Derm Venereol; 2008; 88(6):619-20. PubMed ID: 19002351
[No Abstract] [Full Text] [Related]
11. Extramammary Paget's disease of the penis with features of Bowen's disease.
Yoo KH; Seo SJ; Park J; Han TY; Li K; Song KY; Hong CK
Clin Exp Dermatol; 2009 Dec; 34(8):e999-1000. PubMed ID: 20055883
[No Abstract] [Full Text] [Related]
12. Pagetoid Bowen's disease vs. extramammary Paget's disease.
Raiten K; Paniago-Pereira C; Ackerman AB
J Dermatol Surg; 1976 Mar; 2(1):24-5. PubMed ID: 181411
[No Abstract] [Full Text] [Related]
13. Immunohistology is valuable in distinguishing between Paget's disease, Bowen's disease and superficial spreading malignant melanoma.
Reed W; Oppedal BR; Eeg Larsen T
Histopathology; 1990 Jun; 16(6):583-8. PubMed ID: 1695889
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical distinction of Paget's disease from Bowen's disease and superficial spreading melanoma with the use of monoclonal cytokeratin antibodies.
Shah KD; Tabibzadeh SS; Gerber MA
Am J Clin Pathol; 1987 Dec; 88(6):689-95. PubMed ID: 2446491
[TBL] [Abstract][Full Text] [Related]
15. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
[TBL] [Abstract][Full Text] [Related]
16. Extramammary Paget's disease with bowenoid histologic features accompanied by an ectopic lesion on the upper abdomen.
Nagai Y; Ishibuchi H; Takahashi M; Shimizu A; Matsushima Y; Tamura A; Ishikawa O
J Dermatol; 2005 Aug; 32(8):670-3. PubMed ID: 16334870
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of inducible nitric oxide synthase in skin cancers.
Kagoura M; Matsui C; Toyoda M; Morohashi M
J Cutan Pathol; 2001 Oct; 28(9):476-81. PubMed ID: 11553314
[TBL] [Abstract][Full Text] [Related]
18. Mixed carcinoma in situ: an immunohistochemical study.
Peralta OC; Barr RJ; Romansky SG
J Cutan Pathol; 1983 Oct; 10(5):350-8. PubMed ID: 6313778
[TBL] [Abstract][Full Text] [Related]
19. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
Hughes JH; Robinson RA
Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
[TBL] [Abstract][Full Text] [Related]
20. Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma.
Ito T; Tsuji G; Ohno F; Nakahara T; Uchi H; Furue M
Mod Pathol; 2017 Jul; 30(7):919-927. PubMed ID: 28339425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
